Craig W. Philips

Craig W. Philips Email and Phone Number

Founding Partner @ Pack Ventures
Seattle, WA, US
Craig W. Philips's Location
Seattle, Washington, United States, United States
About Craig W. Philips

Senior executive/Board Member with broad based global pharmaceutical/biotechnology experience. Over twenty Years of Big Pharma experience through all stages of drug and corporate evolution. Ten Years of small pharma and start-up experience. Co-Founder/Board member/Advisor for startup companies (PVP Biologics, (sold to Takeda), Abacus Bioscience, MedsForAll, Transcellular Therapeutics) . Today, I am focused on corporate transactions including M&A and strategic transactions, equity financing, developing markets for pharma products, and building and leading highly effective teams. My expertise includes partnering, corporate strategy, market analysis, and fund raising. An overview of my experience includes roles as CEO, COO, President, VP and GM, and Board Member in both large pharma and emerging companies: - Delivered outstanding corporate/clinical/commercial performance- Public company leadership experience and fundraising- Built companies in multiple medical sectors and developed new corporate capabilities- Led strategy, development, franchise positioning and differentiation for new products. - Multiple successful business development and M&A experiences; both transactional and partnerships.- Built high performing teams, lead key staff development for future corporate leaders.- Served on multiple corporate, industry, and nonprofit Boards of Directors.

Craig W. Philips's Current Company Details
Pack Ventures

Pack Ventures

View
Founding Partner
Seattle, WA, US
Craig W. Philips Work Experience Details
  • Pack Ventures
    Founding Partner
    Pack Ventures
    Seattle, Wa, Us
  • Kineta, Inc.
    President
    Kineta, Inc. 2013 - Present
    Seattle, Wa, Us
    Private biotech company focused on developing leading edge therapeutics in high need therapeutic areas for immuno-oncology and chronic pain. Primary corporate focus is discovery and drug development through translational development and into the clinic, followed by corporate partnering. Concluded a $350 million strategic partnering transaction with Genentech for a non-opioid chronic pain drug program and sold a preclinical IO program to Pfizer.
  • Pack Ventures
    Founding Partner
    Pack Ventures 2021 - Present
    Seattle, Us
  • Abacus Bioscience Inc
    Board Member, Co-Founder
    Abacus Bioscience Inc 2015 - Present
    Seattle, Wa, Us
  • Whetstone Ventures Llc
    General Partner
    Whetstone Ventures Llc 2014 - Present
  • Cbi Co Ltd
    Board Member
    Cbi Co Ltd 2021 - 2022
  • University Of Washington
    Entrepreneur-In-Residence
    University Of Washington 2012 - 2017
    Seattle, Wa, Us
    Provided UW academic researchers with real-world insights about the technologies in development at the university focusing on financing/development/commercialization process. Collaborate with faculty and spin out companies in life science fields and emerging technologies. Develop corporate strategy, funding plans, and growth/exit plans. Serve as an independent advisor/board member/founder to start-up companies including CanCure LLC, Abacus Biosciences Inc., EnTox Sciences, TransCellular Therapeutics Inc., NovaTheraNostics Inc., and PVP Biologics Inc. including expertise in target markets, product development, and fundraising strategies across life science, IT, and engineering fields.Co-Founder, advisor or board member for life science spin out companies including NovaTheraNostics Inc, PvP Biologics Inc, Abacus Bioscience Inc, EnTox Sciences, CanCure BioPharma Inc and TransCellular Therapeutics Inc.
  • Seattle University
    Adjunct Professor And Guest Lecturer
    Seattle University 2014 - 2016
    Seattle, Wa, Us
    Adjunct faculty role teaching Management Strategy at the Albers School of Business and Economics Management and a lecturer in Business Ethics. Mentor for MBA students interested in careers in life sciences.Seattle University, founded in 1891, is a Jesuit Catholic university and law school More than 7,400 students are enrolled in undergraduate and graduate programs within eight schools and colleges. The Albers School of Business is ranked as one of the top 50 private Business Schools in the nation.
  • Cell Therapeutics, Inc.
    President
    Cell Therapeutics, Inc. 2008 - 2012
    Seattle, Wa, Us
    CTI is committed to developing, acquiring, and commercializing innovative treatments for cancer. My role focused on day-to-day company operations – commercial, finance, clinical, regulatory, manufacturing and fund raising (over $300m raised). Worked closely with CEO/Board on strategic issues relating to corporate partnering, financing, and company strategy, as well as new product development and M&A activities. Extensive interface with the Board of Directors. Closely involved with audit, board development, and governance committees. Principal responsibility for major corporate partnerships (including Novartis, Spectrum, Chroma, Cephalon (Teva)). Successful M&A activity with in- and out-licensing of several products. Successful EU regulatory approval of lead compound. Staff: 75+
  • Bayer Oncology
    Vice President And General Manager
    Bayer Oncology 2006 - 2008
    Leverkusen, North Rhine-Westphalia, De
    Head, US Cancer Portfolio. US P&L Responsibility for solid and liquid cancer drugs with a team of over 150 people (Nexavar, Leukine, Campath, Fludara). Member of the US Executive Committee. Integrated and relocated the Bayer and Berlex oncology organizations in the US. Responsible for leading partnerships with Bayer/Onyx, Bayer/Genzyme, others.
  • Berlex Biosciences
    Vice President And General Manager, Head Us Oncology
    Berlex Biosciences 2004 - 2007
    Us
    P&L responsibility for the oncology business in the US. Member of the Global Oncology Leadership Team.
  • Schering-Plough Pharmaceuticals
    General Manager
    Schering-Plough Pharmaceuticals Jun 2000 - Dec 2003
    Global Marketing, launch of Intron A in Hepatitis and Hematology. Head of Hospital/Oncology Business in Canada, GM in Thailand/Laos/Cambodia, GM in Australia and New Zealand. Launch of Intron A, Rebetron, Temodal, Remicade, Asmanex, Nasonex, Claritin D
  • Schering-Plough Pharmaceuticals
    General Manager - Thailand
    Schering-Plough Pharmaceuticals 1997 - 2000
  • Schering-Plough Pharmaceuticals
    Business Unit Head, Oncology (Canada)
    Schering-Plough Pharmaceuticals 1992 - 1997
  • Schering Plough
    Senior Manager Global Oncology
    Schering Plough 1989 - 1992
    Lead the global commercial launch program for INTRON A in oncology and virology.
  • Bristol Myers
    Marketing And Sales, Oncology, Cns, Antiinfectives, Cardiology
    Bristol Myers 1984 - 1989
    Lawrence Township, Nj, Us

Craig W. Philips Skills

Oncology Pharmaceutical Industry Biotechnology Lifesciences Biopharmaceuticals Cardiology Clinical Development Strategy Life Sciences Clinical Trials Clinical Research Cancer Commercialization Pharmaceutical Sales Immunology Product Launch Drug Development Strategic Planning Infectious Diseases Leadership Managed Care Technology Transfer Pharmaceutics Start Ups Medical Devices Cross Functional Team Leadership Drug Discovery Neurology Business Strategy Entrepreneurship Angel Investing Venture Capital Autoimmune Diseases Molecular Diagnostics Celiac Disease Business Development Private Equity Family Office

Craig W. Philips Education Details

  • The Ohio State University Fisher College Of Business
    The Ohio State University Fisher College Of Business
    Masters In Business Administration
  • The Ohio State University
    The Ohio State University
    Marketing
  • Insead
    Insead
    Pharmaceutical Corporate Strategy

Frequently Asked Questions about Craig W. Philips

What company does Craig W. Philips work for?

Craig W. Philips works for Pack Ventures

What is Craig W. Philips's role at the current company?

Craig W. Philips's current role is Founding Partner.

What is Craig W. Philips's email address?

Craig W. Philips's email address is ph****@****leu.edu

What is Craig W. Philips's direct phone number?

Craig W. Philips's direct phone number is +120645*****

What schools did Craig W. Philips attend?

Craig W. Philips attended The Ohio State University Fisher College Of Business, The Ohio State University, Insead.

What are some of Craig W. Philips's interests?

Craig W. Philips has interest in Education, Health.

What skills is Craig W. Philips known for?

Craig W. Philips has skills like Oncology, Pharmaceutical Industry, Biotechnology, Lifesciences, Biopharmaceuticals, Cardiology, Clinical Development, Strategy, Life Sciences, Clinical Trials, Clinical Research, Cancer.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.